Torthaí cuardaigh - Peter Staib

Beachtaigh na torthaí
  1. 1
    Chlamydospore formation on Staib agar as a species‐specific characteristic of <i>Candida dubliniensis</i>

    Chlamydospore formation on Staib agar as a species‐specific characteristic of <i>Candida dubliniensis</i> de réir Peter Staib, Joachim Morschhäuser

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Genetic advances in dermatophytes

    Genetic advances in dermatophytes de réir Maria Grumbt, Michel Monod, Peter Staib

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Sequential gene disruption in <i>Candida albicans</i> by FLP‐mediated site‐specific recombination

    Sequential gene disruption in <i>Candida albicans</i> by FLP‐mediated site‐specific recombination de réir Joachim Morschhäuser, Sonja Michel, Peter Staib

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Differential activation of a <i>Candida albicans</i> virulence gene family during infection

    Differential activation of a <i>Candida albicans</i> virulence gene family during infection de réir Peter Staib, Marianne Kretschmar, Thomas Nichterlein, Herbert Hof, Joachim Morschhäuser

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation

    Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation de réir Bettina Böttcher, Christine Pöllath, Peter Staib, Bernhard Hube, Sascha Brunke

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Keratin Degradation by Dermatophytes Relies on Cysteine Dioxygenase and a Sulfite Efflux Pump

    Keratin Degradation by Dermatophytes Relies on Cysteine Dioxygenase and a Sulfite Efflux Pump de réir Maria Grumbt, Michel Monod, Tsuyoshi Yamada, Christian Hertweck, Jiří Kunert, Peter Staib

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The dermatophyte species Arthroderma benhamiae: intraspecies variability and mating behaviour

    The dermatophyte species Arthroderma benhamiae: intraspecies variability and mating behaviour de réir Françoise Symoens, Olivier Jousson, Ann Packeu, Marina Fratti, Peter Staib, Bernard Mignon, Michel Monod

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial

    WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a pros... de réir Daniel Hofmann, Ulrike Nitz, Oleg Gluz, Ronald Kates, Timo Schinkoethe, Peter Staib, Nadia Harbeck

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    <i>Candida albicans</i>secreted aspartic proteases 4–6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism

    <i>Candida albicans</i>secreted aspartic proteases 4–6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism de réir Hao Wu, Deborah Downs, Koena Ghosh, Arun K. Ghosh, Peter Staib, Michel Monod, Jordan Tang

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

    Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab de réir Jens M. Chemnitz, Andreas Draube, Christof Scheid, Peter Staib, Armin Schulz, Volker Diehl, D. Söhngen

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Gene Expression Profiling in the Human Pathogenic Dermatophyte <i>Trichophyton rubrum</i> during Growth on Proteins

    Gene Expression Profiling in the Human Pathogenic Dermatophyte <i>Trichophyton rubrum</i> during Growth on Proteins de réir Christophe Zaugg, Michel Monod, Johann Weber, Keith Harshman, Sylvain Pradervand, Jérôme Thomas, Manuel Bueno Sánchez, Karin Giddey, Peter Staib

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo

    Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo de réir Rajesh Kumar Gandhirajan, Peter Staib, Katharina Minke, Iris Gehrke, Günther Plickert, Axel Schlösser, E. Schmitt, Michael Hallek, Karl‐Anton Kreuzer

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Patients with <i>de novo</i> acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

    Patients with <i>de novo</i> acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients de réir Claudia Schoch, Torsten Haferlach, Detlef Haase, Christa Fonatsch, Helmut Löffler, Brigitte Schlegelberger, Peter Staib, Maria Cristina Sauerland, Achim Heinecke, Thomas Büchner, Wolfgang Hiddemann

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

    Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marke... de réir Susanne Schnittger, Claudia Schoch, Martin Dugas, Wolfgang Kern, Peter Staib, Christian Wuchter, Helmut Löffler, Cristina M. Sauerland, Hubert Serve, Thomas Büchner, Torsten Haferlach, Wolfgang Hiddemann

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Factors Supporting Cysteine Tolerance and Sulfite Production in Candida albicans

    Factors Supporting Cysteine Tolerance and Sulfite Production in Candida albicans de réir Florian Hennicke, Maria Grumbt, Ulrich Lermann, Nico Ueberschaar, Katja Palige, Bettina Böttcher, Ilse D. Jacobsen, Claudia Staib, Joachim Morschhäuser, Michel Monod, Bernhard Hube, Christian Hertweck, Peter Staib

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia

    Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid... de réir Tamara Alpermann, Susanne Schnittger, Christiane Eder, Frank Dicker, Manja Meggendorfer, Wolfgang Kern, C Schmid, Carlo Aul, Peter Staib, Clemens‐Martin Wendtner, N. Schmitz, Claudia Haferlach, Torsten Haferlach

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    A novel hierarchical prognostic model of AML solely based on molecular mutations

    A novel hierarchical prognostic model of AML solely based on molecular mutations de réir Vera Grossmann, Susanne Schnittger, Alexander Kohlmann, Christiane Eder, Andreas Roller, Frank Dicker, Christoph Schmid, Clemens‐Martin Wendtner, Peter Staib, Hubert Serve, Karl‐Anton Kreuzer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells

    Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells de réir Annette Schmidt, Dennis Ladage, Timo Schinköthe, Ursula Klausmann, Christoph Ulrichs, Franz‐Josef Klinz, Klara Brixius, Stefan Arnhold, Biren Desai, Uwe Mehlhorn, Robert H. G. Schwinger, Peter Staib, Klaus Addicks, Wilhelm Bloch

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial de réir Thomas Elter, Peter Borchmann, H. Schulz, Marcel Reiser, Sven Trelle, Roland Schnell, Markus Jensen, Peter Staib, Timo Schinköthe, H. Stützer, Jürgen Rech, Martin Gramatzki, Walter E. Aulitzky, Ibrahim Hasan, Andreas Josting, Michael Hallek, Andreas Engert

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

    Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response de réir Sibylle Loibl, Andreas Schneeweiß, Jens Huober, Michael Braun, Julia Rey, Jens‐Uwe Blohmer, Jenny Furlanetto, D M Zahm, Claus Hanusch, Jörg Thomalla, Christian Jackisch, Peter Staib, Theresa Link, Kerstin Rhiem, Christine Solbach, Peter A. Fasching, Valentina Nekljudova, Carsten Denkert, Michael Untch

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: